• In August 2026, CACI International Inc. opened a 61,000-square-foot Manufacturing Center of Excellence for Defense Electronics near Rochester, New York, expanding its production footprint for advanced electronic warfare technologies and supporting the U.S. Army’s Terrestrial Layer System Brigade Combat Team Manpack program.
• Alongside this capacity build-out, CACI International Inc. was selected as one of 15 awardees on the US$981 million NITE-STAR IDIQ with the U.S. Space Force, underscoring its role in delivering live, virtual, and constructive space test and training technologies that also ripple through a network of smaller upstate New York suppliers.
• We’ll now examine how CACI’s new defense electronics manufacturing hub could influence its investment narrative around technology-led federal contracts.

We've uncovered the 12 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

CACI International Investment Narrative Recap

To own CACI, you need to believe in its ability to win and execute complex, technology-heavy federal contracts while managing heavy exposure to U.S. government budgets and procurement cycles. The new Rochester Manufacturing Center of Excellence and the NITE-STAR award strengthen its position in electronic warfare and space test systems, but they do not remove near term risks around contract timing, budget uncertainty, or execution in scaling newer production lines.

The NITE-STAR IDIQ award with the U.S. Space Force is especially relevant here, because it sits squarely in the same advanced electronic warfare and space-oriented mission set that the Rochester facility is designed to support. While the IDIQ is shared among 15 awardees, it reinforces CACI’s role in live, virtual, and constructive test and training environments, which many investors already view as a key catalyst for higher quality, technology-led federal work.

Yet beneath this growth opportunity, investors should also be aware of how concentrated federal spending and contract consolidation could...

CACI International's narrative projects $12.0 billion revenue and $758.9 million earnings by 2029. This requires 9.3% yearly revenue growth and about a $222 million earnings increase from $536.9 million today.

Uncover how CACI International's forecasts yield a $654.93 fair value, in line with its current price.

Exploring Other Perspectives

Some of the most optimistic analysts were already assuming CACI could reach about US$12.9 billion in revenue and roughly US$743 million in earnings by 2029, and they see contract consolidation as a tailwind rather than a procurement risk. If you lean toward that view, the Rochester build out and NITE-STAR work might strengthen your case, but they also highlight how far apart reasonable opinions can be and why it is worth weighing several narratives before deciding where you stand.

Explore 4 other fair value estimates on CACI International - why the stock might be worth just $654.93!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your CACI International research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
• Our free CACI International research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate CACI International's overall financial health at a glance.

No Opportunity In CACI International?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

• Capitalize on the AI infrastructure supercycle with our selection of the 55 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• The latest GPUs need a type of rare earth metal called Neodymium and there are only 28 companies in the world exploring or producing it. Find the list for free.
• Find 48 companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.